In reply: Sugammadex in end-stage renal disease: too early for a "free-pass"

Can J Anaesth. 2021 Feb;68(2):266-267. doi: 10.1007/s12630-020-01861-8. Epub 2020 Nov 18.

Authors

J Ross Renew¹, Steven B Porter², Ivan Porter³, Stephania Paredes²

Affiliations

¹ Department of Anesthesiology and Perioperative Medicine, Mayo Clinic Florida, Jacksonville, FL, USA. renew.j@mayo.edu.
² Department of Anesthesiology and Perioperative Medicine, Mayo Clinic Florida, Jacksonville, FL, USA.
³ Division of Nephrology, Mayo Clinic Florida, Jacksonville, FL, USA.

PMID: 33210221
DOI: 10.1007/s12630-020-01861-8

No abstract available

Publication types

Letter
Comment

MeSH terms

Cohort Studies
Humans
Kidney Failure, Chronic*
Rocuronium
Sugammadex

Substances

Sugammadex
Rocuronium